We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.75B
AUM Growth
+$529M
Cap. Flow
-$138M
Cap. Flow %
-2.91%
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162

Sector Composition

Rank Sector Weight
1 Healthcare 32.35%
2 Technology 15.53%
3 Financials 11.99%
4 Real Estate 8.48%
5 Materials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAT
301
American Assets Trust
AAT
$1.38B
$1.79M 0.04%
+93,281
New +$1.75M
VRDN icon
302
Viridian Therapeutics
VRDN
$2.55B
$1.78M 0.04%
74,836
+11,293
+18% +$290K
GRTX
303
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$1.78M 0.04%
570,506
-143,025
-20% -$426K
JAZZ icon
304
Jazz Pharmaceuticals
JAZZ
$16.7B
$1.76M 0.04%
14,214
-12,610
-47% -$1.7M
ALGN icon
305
Align Technology
ALGN
$12B
$1.73M 0.04%
4,891
-234
-5% -$74.5K
LCID icon
306
PUT
Lucid Motors
LCID
$2.75B
$1.73M 0.04%
+70,000
New +$4.99M
HHLA
307
DELISTED
HH&L Acquisition Co.
HHLA
$1.7M 0.04%
162,326
-3,658
-2% -$38.1K
CCK icon
308
Crown Holdings
CCK
$13.2B
$1.67M 0.04%
+19,224
New +$1.58M
QURE icon
309
uniQure
QURE
$3.15B
$1.65M 0.03%
143,965
+68,890
+92% +$1.31M
BCRX icon
310
BioCryst Pharmaceuticals
BCRX
$2.38B
$1.64M 0.03%
232,463
+6,699
+3% +$53.8K
CORS
311
DELISTED
Corsair Partnering Corporation
CORS
$1.61M 0.03%
155,244
-3,499
-2% -$36K
ETNB
312
DELISTED
89bio
ETNB
$1.59M 0.03%
83,838
+27,899
+50% +$490K
CVNA icon
313
PUT
Carvana
CVNA
$75.1B
$1.57M 0.03%
5,000,000
NBR icon
314
Nabors Industries
NBR
$1.23B
$1.57M 0.03%
+16,850
New +$1.71M
OCUL icon
315
Ocular Therapeutix
OCUL
$1.92B
$1.56M 0.03%
302,111
-61,175
-17% -$364K
SNOW icon
316
Snowflake
SNOW
$110B
$1.55M 0.03%
+8,805
New +$1.43M
ICLR icon
317
Icon
ICLR
$12.4B
$1.54M 0.03%
6,145
-173
-3% -$36.7K
ALCYU
318
DELISTED
Alchemy Investments Acquisition Corp 1 Units
ALCYU
$1.54M 0.03%
+150,000
New +$1.52M
FNA
319
DELISTED
Paragon 28, Inc.
FNA
$1.53M 0.03%
86,285
+61,485
+248% +$1.1M
SRRK icon
320
Scholar Rock
SRRK
$6.41B
$1.53M 0.03%
202,581
+67,025
+49% +$506K
ANNX icon
321
Annexon
ANNX
$918M
$1.5M 0.03%
425,556
+258,649
+155% +$1.13M
XENE icon
322
Xenon Pharmaceuticals
XENE
$6.24B
$1.49M 0.03%
38,676
-24,715
-39% -$982K
RDNW
323
RideNow Group
RDNW
$264M
$1.47M 0.03%
118,896
-31,104
-21% -$290K
AONC
324
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$1.47M 0.03%
142,301
-3,239
-2% -$33.2K
DNLI icon
325
Denali Therapeutics
DNLI
$3.92B
$1.44M 0.03%
+48,952
New +$1.38M

Similar funds

UBS O'Connor's Q2 2023 Portfolio in Review

As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

UBS O'Connor's Q2 2023 filing shows 128 new, 150 increased, 259 reduced and 162 closed positions. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M. The largest sale was First Horizon, an estimated $179M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
  • UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
  • UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
  • UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
  • UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
  • UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.